Groveland Family Medical Center | |
18661 Highway 120 Groveland CA 95321 | |
(209) 962-7121 | |
(209) 533-7696 |
Full Name | Groveland Family Medical Center |
---|---|
Speciality | Family Medicine |
Location | 18661 Highway 120, Groveland, California |
Authorized Official Name and Position | Andrew D. Jahn (CEO) |
Authorized Official Contact | 2095365011 |
Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
Mailing Address | Practice Location Address |
---|---|
Groveland Family Medical Center 14542 Lolly Ln Sonora CA 95370-9226 Ph: (209) 536-3900 | Groveland Family Medical Center 18661 Highway 120 Groveland CA 95321 Ph: (209) 962-7121 |
NPI Number | 1356332274 |
---|---|
Provider Enumeration Date | 10/31/2005 |
Last Update Date | 09/28/2016 |
Identifier | Type | State | Issuer |
---|---|---|---|
1356332274 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | (* (Not Available)) | Primary |
News Archive
American Biosurgical, LLC a privately owned, custom medical cable manufacturer actively engaged in the design, development and production of innovative medical interconnect technologies for the world's leading medical device companies has announced the acquisition of MTI Corporation, a high precision, low volume custom medical cable manufacturer based in North Carolina.
A treatment for psoriasis could be repurposed to treat a rare but aggressive form of youth cancer, new findings from the Garvan Institute of Medical Research suggest.
Researchers at the University of California, San Diego School of Medicine have, for the first time, clearly defined the epidemiology of gastrointestinal stromal tumors (GIST), which occur primarily in the lining of the stomach and small intestine.
A team of researchers led by Dr. Goutham Narla at Case Western Reserve University School of Medicine in collaboration with scientists at Mount Sinai School of Medicine in New York, have discovered a previously unrecognized signaling network disrupted in lung cancer that can be turned back on by a novel combination of two previously approved FDA drugs.
Alexion Pharmaceuticals, Inc. today announced new research evaluating the substantial disease burden of paroxysmal nocturnal hemoglobinuria, an ultra-rare blood disorder, in patients worldwide. The International PNH Registry, involving 580 patients from 99 sites in 14 countries as of May 2010, found that the debilitating symptoms and life-threatening complications of PNH are similar across patient populations around the world.
› Verified 7 days ago
Katherine R. Newcomb M.d. Medical Corp Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 18661 Main St, Groveland, CA 95321 Phone: 209-962-7121 Fax: 209-962-0665 |